Financial Statements — ICCM
Balance Sheet
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Cash & Equivalents | 5.38 | 9.65 | 3.03 | 13.47 |
| Accounts Receivable | 0.12 | 0.33 | 0.12 | 0.18 |
| Inventory | 2.33 | 1.97 | 2.75 | 2.65 |
| Total Current Assets | 9.02 | 13.33 | 20.43 | 21.56 |
| Property, Plant & Equipment | 1.13 | 1.38 | 1.52 | 1.10 |
| Total Non-current Assets | 1.57 | 2.03 | 2.26 | 2.25 |
| Total Assets | 10.59 | 15.36 | 22.69 | 23.81 |
| Accounts Payable | -- | 0.70 | 0.65 | 0.94 |
| Total Current Liabilities | 7.64 | 4.48 | 3.86 | 4.33 |
| Long-term Debt | 0.06 | -- | -- | -- |
| Total Non-current Liabilities | 0.06 | 0.27 | 0.40 | 0.61 |
| Total Liabilities | 7.70 | 4.75 | 4.25 | 4.94 |
| Retained Earnings | (112.33) | (96.75) | (83.07) | (67.40) |
| Total Stockholder Equity | 2.89 | 10.61 | 18.44 | 18.88 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Total Revenue | 1.25 | 1.75 | 1.65 | 1.51 |
| Cost of Revenue | 0.90 | 0.96 | 0.89 | 0.69 |
| Gross Profit | 0.35 | 0.80 | 0.75 | 0.82 |
| Research & Development | 3.38 | 3.54 | 4.19 | 4.65 |
| Selling, General & Admin | 1.87 | 1.85 | 2.35 | 3.34 |
| Total Operating Expenses | 7.39 | 7.68 | 8.79 | 9.52 |
| Operating Income | (7.04) | (6.88) | (8.04) | (8.71) |
| Net Income | (6.95) | (6.69) | (7.66) | (8.97) |
| Basic EPS | 0.12 | 0.14 | 0.17 | 0.24 |
| Diluted EPS | 0.12 | 0.14 | 0.17 | 0.24 |
Cash Flow Statement
(in millions USD)| Metric | Q2
2025 | Q2
2024 | Q2
2023 | Q2
2022 |
|---|
| Operating Cash Flow | (6.85) | (5.21) | (6.56) | (6.84) |
| Capital Expenditures | 0.03 | 0.03 | 0.32 | 0.49 |
| Free Cash Flow* | (6.88) | (5.25) | (6.88) | (7.34) |
| Investing Cash Flow | (0.03) | (0.35) | (13.97) | (4.77) |
| Financing Cash Flow | 4.65 | 4.73 | -- | 0.00 |
* Derived from reported values
